Abstract:ABSTRACT Metabolic syndrome (MetS) represents a cluster of major risk factors known to be associated with the development of aging-related diseases, such as cardiovascular disease and diabetes. Telomere length (TL) is often used as a cellular marker for biological age. Shorter TL indicates increased biological age. It is unknown whether maintenance of a short TL could be predictive for onset of metabolic diseases associated with increasing biological age. A number of studies found significant associations between shorter TL and dysregulated MetS components, but other studies did not confirm this finding. This cohort study investigated the relationship between shorter baseline TL and a worse metabolic profile with less favorable trajectories of MetS components over a 6-year follow-up. Participants included 2842 men and women aged 18 to 65 years who were part of The Netherlands Study of Depression and Anxiety, an ongoing prospective cohort study with 6-year follow-up. Telomere length from leukocytes was determined using quantitative polymerase chain reaction. Metabolic syndrome components (waist circumference, triglycerides, high-density lipoprotein &lsqb;HDL&rsqb;, cholesterol, fasting glucose, and systolic and diastolic blood pressure) were determined at baseline and after 2 and 6 years. Adjustments were made at baseline and 2- and 6-year follow-up for covariates (sociodemographic, lifestyle, and health factors) that could affect cross-sectional and longitudinal analyses. Shorter TL was cross-sectionally associated with a higher number of MetS abnormalities (&bgr; = 0.075, SE = 0.023, P = 0.001), higher waist circumference (&bgr; = 0.647, SE = 0.238, P = 0.007), triglycerides (&bgr; = .038, SE = 0.009, P < 0.001), and fasting glucose (&bgr; = 0.011, SE = 0.003, P < 0.001), and with lower HDL cholesterol (&bgr; = − 0.016, SE = 0.008, P = 0.05). No consistent patterns of association between TL and hypertension were found. Baseline differences progressively diminished over time; however, shorter baseline TL was still significantly associated with a worse level for most MetS components at both the 2- or 6-year follow-up. These findings show that cellular aging, as assessed by TL, is associated with a higher number of MetS abnormalities (representing a more severe metabolic risk profile) that persists even after a period of 6 years. The data suggest that a shorter TL could be predictive for the onset of various aging-related somatic diseases through its effect on metabolic alterations.

Effects of Age and Biological Age-Determining Factors on Telomere Length in Type 2 Diabetes Mellitus Patients

Shortening of the leucocytes' telomeres length in T2DM independent of age and telomerase activity

Association of Telomere Length and Serum Vitamin D Levels with Type 2 Diabetes Mellitus and its Related Complications: A Possible Future Perspective

The association of metabolic syndrome with telomere length as a marker of cellular aging: a systematic review and meta-analysis

The association between telomere length and diabetes mellitus: accumulated evidence from observational studies

Association Between Elder Abuse and Telomere Shortening in Older Adults: A 2‐year Prospective Study

Shortened Leukocyte Telomere Length Is Associated With Glycemic Progression in Type 2 Diabetes: A Prospective and Mendelian Randomization Analysis

Telomere Length Variations in Aging and Age-Related Diseases

Telomere Length as a Marker of Cellular Aging Is Associated With Prevalence and Progression of Metabolic Syndrome

Telomeres do not always shorten over time in individuals with type 1 diabetes

The influence of TERC, TERT and ACYP2 genes polymorphisms on plasma telomerase concentration, telomeres length and T2DM

β-cell telomere attrition in diabetes: inverse correlation between HbA1c and telomere length

Salivary Telomere Length and the Risks of Prediabetes and Diabetes among Middle-Aged and Older Adults: Findings from the Health and Retirement Study.

17-Year Follow-Up of Association Between Telomere Length and All-Cause Mortality, Cardiovascular Mortality in Individuals with Metabolic Syndrome: Results from the NHANES Database Prospective Cohort Study

The Shortening of Leukocyte Telomere Length Relates to DNA Hypermethylation of LINE-1 in Type 2 Diabetes Mellitus.

Telomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trial

Leucocyte Telomere Shortening in Relation to Newly Diagnosed Type 2 Diabetic Patients with Depression

Diabetes mellitus correlates with increased biological age as indicated by clinical biomarkers

Abstract 9556: Role of Telomere in Endothelial Dysfunction in Type 2 Diabetic Mice

Unravelling the role of telomere shortening with ageing and their potential association with diabetes, cancer, and related lifestyle factors

Leucocyte Telomere Length and Glucose Tolerance Status in Mixed-Ancestry South Africans